Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Debt / NOTE 1.250% 5/0
-
Market price (% of par)
-
142.19%
-
Total 13F principal
-
$200,523,000
-
Principal change
-
-$2,108,000
-
Total reported market value
-
$285,296,864
-
Number of holders
-
19
-
Value change
-
-$3,839,925
-
Number of buys
-
10
-
Number of sells
-
7
Institutional Holders of NEOGENOMICS INC - NOTE 1.250% 5/0 as of Q2 2021
As of 30 Jun 2021,
NEOGENOMICS INC - NOTE 1.250% 5/0 was held by
19 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$200,523,000
in principal (par value) of the bond.
The largest 10 bondholders included
WOLVERINE ASSET MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., UBS ASSET MANAGEMENT AMERICAS INC, CITADEL ADVISORS LLC, Polar Asset Management Partners Inc., CAPSTONE INVESTMENT ADVISORS, LLC, D. E. Shaw & Co., Inc., BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Linden Advisors LP.
This page lists
19
institutional bondholders reporting positions
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.